EN
HI
Aarti Drugs Chart
Aarti Drugs Share Key Metrics
Volume
80931.00
Market Cap
3239.63 CR
LTQ@LTP
2@354.95
ATP
352.41
Var Margin
18.67 %
Circuit Range
282.2-423.2
Delivery %
40.95 %
Value
2.85 CR
ASM/GSM
No
Market Lot
1
Summary
At 6 Apr, 2026 | 15:45, Aarti Drugs share price stands at ₹354.95, showing a 2.25% 0.64 for the day. The stock’s intraday movement has stayed between ₹345.30 and ₹357.00, while on a 52-week basis it has fluctuated from ₹312.00 to ₹564.05.
In terms of trading activity, Aarti Drugs has recorded a volume of 80931 shares, with a market capitalisation of ₹91270000. The stock’s Average Traded Price (ATP) stands at ₹35241, while the Last Traded Quantity at Last Traded Price (LTQ@LTP) is 2,35495. The stock operates within a circuit range of ₹282.2-423.2, with a Value of ₹2.85 CR. The Delivery Percentage for the day is 40.95%. Additionally, Aarti Drugs currently falls under the No framework, and trades with a market lot size of 1.
Aarti Drugs Fundamentals
View MoreP/E Ratio
15.86
P/B Ratio
2.13
Div. Yield
0.28
Sector P/E
60.59
Sector P/B
3.25
Sec. Div. Yield
0.59
Aarti Drugs Resistance and Support
Pivot 347.62
Resistance
First Resistance
359.69
Second Resistance
366.67
Third Resistance
378.74
Support
First Support
340.64
Second Support
328.57
Third Support
321.59
Aarti Drugs Corporate Actions
| Date | Agenda |
|---|---|
| 2026-02-03 | Quarterly Results & Interim Dividend |
| 2025-11-07 | Quarterly Results |
| 2025-07-18 | Quarterly Results |
| 2025-05-06 | Audited Results |
| 2025-01-29 | Quarterly Results & Interim Dividend |
Aarti Drugs News
Aarti Drugs Ltd - 524348 - Announcement under Regulation 30 (LODR)-Credit Rating
ICRA reaffirmed Aarti Drugs' credit ratings for long-term fund-based facilities at [ICRA] AA- (Stable) and short-term non-fund based facilities at [ICRA] A1+. The total rated amount stands at ₹1,452.80 crore, covering existing and proposed term loans, and fund-based cash credit.
Mar 24 2026 18:03:00
Aarti Drugs Limited
ICRA Limited reaffirmed the credit ratings for Aarti Drugs' various facilities, with long-term fund-based facilities rated [ICRA] AA- (Stable) and short-term facilities rated [ICRA] A1+. The reaffirmation covers total facilities of ₹1,452.80 crores, ensuring continued financial stability.
Mar 24 2026 18:03:00
Read More
About Aarti Drugs
NSE : 4481
BSE : 524348
ISIN : INE767A01016
Aarti Drugs Management
| Name | Position |
|---|---|
| Mr. Chandrakant V Gogri | Chairman Emeritus |
| Mr. Prakash M Patil | Chairman & M.D & CEO |
Aarti Drugs Similar Stocks
Indraprastha Medical Corporation Ltd.
410.85
11.25 (2.82%)
SMS Pharmaceuticals Ltd.
390.55
2.30 (0.59%)
Senores Pharmaceuticals Ltd.
778.15
-6.10 (0.78%)
Artemis Medicare Services Ltd.
229.53
5.32 (2.37%)
Gujarat Themis Biosyn Ltd.
261.18
9.87 (3.93%)
RPG Life Sciences Ltd.
1900.50
-20.70 (1.08%)
Advanced Enzyme Technologies Ltd.
278.80
6.30 (2.31%)
Gufic Biosciences Ltd.
290.20
1.60 (0.55%)
Orchid Pharma Ltd.
530.05
6.25 (1.19%)
Bliss GVS Pharma Ltd.
237.28
3.10 (1.32%)
Aarti Drugs FAQs
The Buying Price of Aarti Drugs share is 354.95 For live prices and instant trading, you can log in to your Choice trading account or open a Free Demat account with Choice.
To buy Aarti Drugs stocks, log in to your Choice trading account. If you don’t have one, open a Choice Demat account. Then, add funds, search for Aarti Drugs, choose your preferred order type, and place the trade.
The Price-to-earnings (P/E) ratio of Aarti Drugs shares is 15.86. You can compare it with the sector average for relative valuation.
The Price to Book (P/B) ratio Aarti Drugs shares is 2.13. Useful to assess the stock's value relative to its book value.
To assess Aarti Drugs’s valuation compare Sector P/E, P/B which are 60.59 & 3.25 with sector averages, along with growth rates and financial metrics.
The Market Cap of Aarti Drugs is 3239.63 CR. It indicates the company's size category and trading liquidity.
The 52 week high and low prices of Aarti Drugs share price is 564.05 & 312.00. They indicate price extremes, trading ranges, volatility measures, potential support/resistance, and price momentum.
Aarti Drugs belongs to the Healthcare sector.
